CH529790A - Verfahren zur Herstellung von Cephalexinmonohydrat - Google Patents
Verfahren zur Herstellung von CephalexinmonohydratInfo
- Publication number
- CH529790A CH529790A CH537470A CH537470A CH529790A CH 529790 A CH529790 A CH 529790A CH 537470 A CH537470 A CH 537470A CH 537470 A CH537470 A CH 537470A CH 529790 A CH529790 A CH 529790A
- Authority
- CH
- Switzerland
- Prior art keywords
- preparation
- cephalexin monohydrate
- cephalexin
- monohydrate
- Prior art date
Links
- 229940047526 cephalexin monohydrate Drugs 0.000 title 1
- YGZIWEZFFBPCLN-UHFFFAOYSA-N n,3-bis(2-chloroethyl)-4-hydroperoxy-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine Chemical compound OOC1CCOP(=O)(NCCCl)N1CCCl YGZIWEZFFBPCLN-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Food-Manufacturing Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81812569A | 1969-04-21 | 1969-04-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH529790A true CH529790A (de) | 1972-10-31 |
Family
ID=25224730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH537470A CH529790A (de) | 1969-04-21 | 1970-04-10 | Verfahren zur Herstellung von Cephalexinmonohydrat |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3531481A (de) |
| JP (1) | JPS505255B1 (de) |
| AT (1) | AT296504B (de) |
| BR (1) | BR6914945D0 (de) |
| CH (1) | CH529790A (de) |
| CS (1) | CS162720B2 (de) |
| DK (1) | DK129458B (de) |
| ES (1) | ES378832A1 (de) |
| GT (1) | GT197016708A (de) |
| NO (1) | NO135068C (de) |
| PL (1) | PL80590B1 (de) |
| SE (1) | SE361318B (de) |
| YU (1) | YU39291B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1317159A (en) * | 1969-09-26 | 1973-05-16 | Glaxo Lab Ltd | Manufacture of cephalosporin compounds |
| US3687948A (en) * | 1970-11-23 | 1972-08-29 | Bristol Myers Co | 7-{8 D-(a-AMINO-a-PHENYLACETAMIDO){9 -3-(4-METHYL-1,3-OXAZOL-2-YLTHIOMETHYL-3-CEPHEM-4-CARBOXYLIC ACID AND SALTS THEREOF |
| US3692781A (en) * | 1971-02-26 | 1972-09-19 | Glaxo Lab Ltd | Recovery of pure cephalexin from acidic reaction mixtures |
| DE2317179C2 (de) * | 1973-04-05 | 1982-11-25 | Bristol-Myers Co., 10154 New York, N.Y. | Verfahren zur Herstellung der relativ wasserunlöslichen kristallinen Form von Cefalexinmonohydrat |
| JPS5621395B2 (de) * | 1973-07-18 | 1981-05-19 | ||
| US4020060A (en) * | 1975-07-22 | 1977-04-26 | Richardson-Merrell Inc. | 7-[α-Amino-ω-(3,4-methylenedioxyphenyl)acylamido]cephalosporanic acid derivatives |
| US4033956A (en) * | 1975-07-22 | 1977-07-05 | Richardson-Merrell Inc. | 7[α-Amino-ω-(2,3-methylenedioxy-phenyl)acylamido]cephalosporanic acid derivatives |
| JPS5474966U (de) * | 1977-11-07 | 1979-05-28 | ||
| IT1126544B (it) * | 1979-12-07 | 1986-05-21 | Dobfar Spa | Procedimento per la preparazione di derivati dell'acido 7-amino-desacetossi cefalosporanico |
| US4775751A (en) * | 1985-06-03 | 1988-10-04 | Eli Lilly & Company | Process for cephalexin hydrochloride alcoholates |
| JPS6293589U (de) * | 1985-11-29 | 1987-06-15 | ||
| US5399686A (en) * | 1993-06-04 | 1995-03-21 | Eli Lilly And Company | Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
| US5374719A (en) * | 1993-06-04 | 1994-12-20 | Eli Lilly And Company | Process for converting loracarbef dihydrate to loracarbef monohydrate |
| US5352782A (en) * | 1993-06-04 | 1994-10-04 | Eli Lilly And Company | Process for preparing crystalline β-lactam monohydrate |
| US5412094A (en) * | 1993-06-28 | 1995-05-02 | Eli Lilly And Company | Bicyclic beta-lactam/paraben complexes |
| US5580977A (en) * | 1995-03-01 | 1996-12-03 | Eli Lilly And Company | Process for preparing loracarbef monohydrate |
| US6001996A (en) * | 1995-05-11 | 1999-12-14 | Eli Lilly And Company | Complexes of cephalosporins and carbacephalosporins with parabens |
| AT406774B (de) * | 1997-02-19 | 2000-08-25 | Takeda Chemical Industries Ltd | Cephalosporinkristalle und deren herstellung |
| US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
| CN113845529B (zh) * | 2021-10-15 | 2024-02-27 | 东南大学 | 一种头孢氨苄共晶化合物及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3382241A (en) * | 1967-02-27 | 1968-05-07 | Lilly Co Eli | Certain orally active cephalosporin antibiotics |
-
1969
- 1969-04-21 US US818125A patent/US3531481A/en not_active Expired - Lifetime
- 1969-12-10 BR BR214945/69A patent/BR6914945D0/pt unknown
-
1970
- 1970-04-10 CH CH537470A patent/CH529790A/de not_active IP Right Cessation
- 1970-04-15 AT AT343670A patent/AT296504B/de not_active IP Right Cessation
- 1970-04-16 YU YU994/70A patent/YU39291B/xx unknown
- 1970-04-20 ES ES378832A patent/ES378832A1/es not_active Expired
- 1970-04-20 PL PL1970140131A patent/PL80590B1/pl unknown
- 1970-04-20 SE SE05433/70A patent/SE361318B/xx unknown
- 1970-04-20 GT GT197016708A patent/GT197016708A/es unknown
- 1970-04-20 NO NO1494/70A patent/NO135068C/no unknown
- 1970-04-20 DK DK197470AA patent/DK129458B/da not_active IP Right Cessation
- 1970-04-21 JP JP45034210A patent/JPS505255B1/ja active Pending
- 1970-04-21 CS CS2694A patent/CS162720B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO135068C (de) | 1977-02-02 |
| CS162720B2 (de) | 1975-07-15 |
| US3531481A (en) | 1970-09-29 |
| BR6914945D0 (pt) | 1973-04-19 |
| ES378832A1 (es) | 1972-07-16 |
| JPS505255B1 (de) | 1975-03-01 |
| NO135068B (de) | 1976-10-25 |
| GT197016708A (es) | 1971-10-12 |
| DK129458B (da) | 1974-10-14 |
| DK129458C (de) | 1975-04-21 |
| AT296504B (de) | 1972-02-25 |
| YU99470A (en) | 1982-02-28 |
| YU39291B (en) | 1984-10-31 |
| PL80590B1 (en) | 1975-08-30 |
| SE361318B (de) | 1973-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT298508B (de) | Verfahren zur Herstellung von Mercaptoalkylalkoxysilanen | |
| CH529790A (de) | Verfahren zur Herstellung von Cephalexinmonohydrat | |
| AT302277B (de) | Verfahren zur Herstellung von Chinondiiminen | |
| CH526566A (de) | Verfahren zur Herstellung von 5-Pyridyl-2-imidazolonen | |
| CH508604A (de) | Verfahren zur Herstellung von Ureidophenylguanidinen | |
| CH533103A (de) | Verfahren zur Herstellung von 4-Acyloxy-azetidin-2-onen | |
| AT304774B (de) | Verfahren zur Herstellung von 16β-Methyl-9α-fluor-steroiden | |
| CH525881A (de) | Verfahren zur Herstellung von 4-Alkylprolinen | |
| CH505041A (de) | Verfahren zur Herstellung von Cycloalkenonen | |
| CH531480A (de) | Verfahren zur Herstellung von Aminoadamantanen | |
| AT319485B (de) | Verfahren zur Herstellung von 19-Norsteroiden | |
| AT296961B (de) | Verfahren zur Herstellung von Alkyldihydroxybenzolen | |
| CH511225A (de) | Verfahren zur Herstellung von Amidophenylthioharnstoffen | |
| CH529108A (de) | Verfahren zur Herstellung von y-Cyanbutyraldiminen | |
| AT308086B (de) | Verfahren zur Herstellung von 1-Alkoxyanthrachinonen | |
| CH530408A (de) | Verfahren zur Herstellung von Chinolylpiperazinen | |
| AT296297B (de) | Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen | |
| AT299905B (de) | Verfahren zur Herstellung von β-Acetoxypivalinaldehyd | |
| CH530358A (de) | Verfahren zur Herstellung von 2-Methyl-4-halogen-but-2-en-1-alen | |
| CH534135A (de) | Verfahren zur Herstellung von O-Carbamoylamidoximen | |
| CH532070A (de) | Verfahren zur Herstellung von 3-Methyl-isoxazol | |
| AT296298B (de) | Verfahren zur Herstellung von N-Tritylimidazolen und -triazolen | |
| AT299251B (de) | Verfahren zur Herstellung von Organo-H-chlorsilanen | |
| AT299907B (de) | Verfahren zur Herstellung von Trimethyl-2-cyclohexen-1-onen | |
| AT294834B (de) | Verfahren zur Herstellung von 4-Alkoxy-piperidinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |